BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12826649)

  • 1. Interstitial pneumonitis related to rituximab therapy.
    Burton C; Kaczmarski R; Jan-Mohamed R
    N Engl J Med; 2003 Jun; 348(26):2690-1; discussion 2690-1. PubMed ID: 12826649
    [No Abstract]   [Full Text] [Related]  

  • 2. Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature.
    Heresi GA; Farver CF; Stoller JK
    Respiration; 2008; 76(4):449-53. PubMed ID: 17596682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial pneumonitis as a side effect of rituximab].
    Kemming JL; van Zeeland RE; Ullmann EF; Mattijssen EJ
    Ned Tijdschr Geneeskd; 2009; 153():A526. PubMed ID: 19785875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma.
    Arai Y; Tadokoro J; Mitani K
    Am J Hematol; 2005 Apr; 78(4):317-8. PubMed ID: 15795913
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature.
    Dhand S; Bahrain H
    Cancer Invest; 2008 Nov; 26(9):913-5. PubMed ID: 19034773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature.
    Subramanian M; Manjunath R; Kilara N; Mohan Rao KN
    J Cancer Res Ther; 2010; 6(3):344-6. PubMed ID: 21119272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.
    Cha SI; Choi KJ; Shin KM; Lim J; Yoo SS; Lee J; Lee SY; Kim CH; Park JY
    Respiration; 2013; 85(2):175. PubMed ID: 23234874
    [No Abstract]   [Full Text] [Related]  

  • 8. Late-onset neutropenia following viral bone marrow depression after rituximab therapy.
    Christopeit M; Haak U; Behre G
    Ann Hematol; 2008 Sep; 87(9):761-2. PubMed ID: 18350295
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab-induced acute severe thrombocytopenia.
    Parajuli R; Hire E; Shah BK
    Br J Haematol; 2010 Jun; 149(6):804. PubMed ID: 20602622
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum sickness following treatment with rituximab.
    Todd DJ; Helfgott SM
    J Rheumatol; 2007 Feb; 34(2):430-3. PubMed ID: 17295433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maintenance therapy with rituximab].
    Krankenpfl J; 2005; 43(7-10):222-4. PubMed ID: 16515293
    [No Abstract]   [Full Text] [Related]  

  • 12. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.
    Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
    Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
    Tobinai K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.
    Mielke F; Schneider-Obermeyer J; Dörner T
    Ann Rheum Dis; 2008 Jul; 67(7):1056-7. PubMed ID: 18556453
    [No Abstract]   [Full Text] [Related]  

  • 15. Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP).
    Swords R; Power D; Fay M; O'Donnell R; Murphy PT
    Am J Hematol; 2004 Sep; 77(1):103-4. PubMed ID: 15307117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
    Forstpointner R; Hänel A; Repp R; Hermann S; Metzner B; Pott C; Hartmann F; Rothmann F; Böck HP; Wandt H; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2253-8. PubMed ID: 12397539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutropenia in patients treated with rituximab.
    Voog E; Morschhauser F; Solal-Céligny P
    N Engl J Med; 2003 Jun; 348(26):2691-4; discussion 2691-4. PubMed ID: 12826650
    [No Abstract]   [Full Text] [Related]  

  • 18. Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.
    Rummel MJ; Al-Batran SE; Kim SZ; Welslau M; Hecker R; Kofahl-Krause D; Josten KM; Dürk H; Rost A; Neise M; von Grünhagen U; Chow KU; Hansmann ML; Hoelzer D; Mitrou PS
    J Clin Oncol; 2005 May; 23(15):3383-9. PubMed ID: 15908650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe interstitial pneumonitis associated with infliximab therapy.
    Chatterjee S
    Scand J Rheumatol; 2004; 33(4):276-7. PubMed ID: 15370726
    [No Abstract]   [Full Text] [Related]  

  • 20. Inefficacy of rituximab in a case of low grade non-Hodgkin's lymphoma with cryoglobulinemia.
    Baronciani D; Angelucci E; Gaziev J; Visani G
    Haematologica; 2002 Jul; 87(7):ELT33. PubMed ID: 12091148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.